17-Acetoxy-6-alpha-methylprogesterone

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

30 API Suppliers, 18 USDMF, 5 CEP/COS, 1 JDMF, 5 KDMF, 14 NDC API, 17 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

4 Suppliers

4 Suppliers

DOSSIERs // Finished Dosage Formulations

148 Dossiers, 41 FDA Orange Book, 55 Europe, 14 Canada, 12 Australia, 16 South Africa, 10 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

TABLET;ORAL - 10MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 400MG/ML
INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

Suppliers, 27 BASF, 20 Kerry, 15 Roquette, 12 Microlex e.U, 10 Gangwal Chemicals, 10 Sigachi Industries, 9 Actylis, 8 Seppic, 7 Gangwal Healthcare, 5 Ideal Cures Pvt Ltd, 5 Nanjing Well Pharmaceutical, 4 SPI Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 3 Vasa Pharmachem, 3 DKSH, 3 Corel Pharma Chem, 2 Seqens, 2 Nomisma Healthcare, 2 Pharmatrans-Sanaq, 2 Ingredion Pharma Solutions, 2 Prachin Chemical, 2 Finar, 1 Alcedo Pharmachem, 1 Jai Radhe Sales, 1 Ulanqab Kema New Material, 1 Clariant, 1 Nanjing Bold Chemical, 1 Evonik, 1 Boai NKY Pharmaceuticals Ltd, 1 Aeon Procare, 1 Pfanstiehl

EXCIPIENTS BY APPLICATIONS

53 Fillers, Diluents & Binders, 27 Coating Systems & Additives, 26 Direct Compression, 25 Solubilizers, 23 Controlled & Modified Release, 20 Thickeners and Stabilizers, 18 Lubricants & Glidants, 17 Parenteral, 17 Granulation, 16 Topical, 12 Co-Processed Excipients, 12 Disintegrants & Superdisintegrants, 11 Taste Masking, 10 Film Formers & Plasticizers, 5 Chewable & Orodispersible Aids, 4 Emulsifying Agents, 3 Surfactant & Foaming Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 46 Finished Drug Prices

MARKET PLACE

8 APIs, 6 DOSSIERS // FDF, 1 CONTRACT SERVICES

PATENTS

1 Health Canada Patents

1 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 3 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

19 News

19 News

Full Screen View

Pfizer Inc

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access t...

Details:

The expanded collaboration is expected to deliver more than 320 million doses of Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Lead Product(s): Medroxyprogesterone Acetate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Sayana Press

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Bill & Melinda Gates Foundation

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Expanded Collaboration August 03, 2023

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for 17-Acetoxy-6-alpha-methylprogesterone

17-Acetoxy-6-alpha-methylprogesterone

17-Acetoxy-6-alpha-methylprogesterone

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 API Suppliers

18 USDMF

5 CEP/COS

1 JDMF

5 KDMF

14 NDC API

17 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

4 Suppliers

DOSSIERs // Finished Dosage Formulations

148 Dossiers

41 FDA Orange Book

55 Europe

14 Canada

12 Australia

16 South Africa

10 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 5MG

INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 400MG/ML

INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

Suppliers

27 BASF

20 Kerry

15 Roquette

12 Microlex e.U

10 Gangwal Chemicals

10 Sigachi Industries

9 Actylis

8 Seppic

7 Gangwal Healthcare

5 Ideal Cures Pvt Ltd

5 Nanjing Well Pharmaceutical

4 SPI Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 DFE Pharma

3 Vasa Pharmachem

3 DKSH

3 Corel Pharma Chem

2 Seqens

2 Nomisma Healthcare

2 Pharmatrans-Sanaq

2 Ingredion Pharma Solutions

2 Prachin Chemical

2 Finar

1 Alcedo Pharmachem

1 Jai Radhe Sales

1 Ulanqab Kema New Material

1 Clariant

1 Nanjing Bold Chemical

1 Evonik

1 Boai NKY Pharmaceuticals Ltd

1 Aeon Procare

1 Pfanstiehl

EXCIPIENTS BY APPLICATIONS

53 Fillers, Diluents & Binders

27 Coating Systems & Additives

26 Direct Compression

25 Solubilizers

23 Controlled & Modified Release

20 Thickeners and Stabilizers

INJECTABLE;INJECTION - 100MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons